NEO - NeoGenomics, Inc. O‘sish sur’atiga tuzatilgan narx-foyda
NeoGenomics, Inc. (NEO) patent himoyasi va tibbiyot markazlari bilan yaqin aloqalardan foydalangan holda, genetik o'sma tahlili va biomarkerlar orqali daromad keltiradi. PEG koeffitsiyentiga asoslangan past baholanganlik darajasi baholashning zarbalarga chidamliligini namoyish etadi, 1.14 qiymati esa ushbu darajani xarakterlaydi. Biznesning o'sishi farmatsevtika kompaniyalari bilan tuzilgan yangi shartnomalar, RaDaR suyuq biopsiyasining joriy etilishi va ichki xarajatlarning optimallashtirilishi hisobiga ta'minlanmoqda.
NeoGenomics, Inc. (NEO) kompaniyasining tahliliy kesimlari
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi statistikasi:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati NeoGenomics, Inc.|NEO - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzdorlikning o'z kapitaliga nisbati neogenomics.com|NEO - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar NeoGenomics Laboratories|NEO - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi NeoGenomics|Shoshilinch likvidlik neogenomics.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
NEO - Kompaniyaning sof foydasi|Kelajakdagi foyda NeoGenomics, Inc.|NEO - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati NeoGenomics Corp|NEO - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti NeoGenomics Laboratories|NEO - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda NeoGenomics|NEO - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi neogenomics.com|NEO - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi NeoGenomics, Inc.
Kompaniyaning umumiy tahlili:NEO - NeoGenomics Inc
NeoGenomics, Inc. (NEO) maqsadli terapiyani rivojlantirish uchun laboratoriya testlari va farmatsevtika tadqiqotlarini integratsiya qilish orqali muhim onkologik diagnostika infratuzilmasini yaratmoqda. PEG koeffitsiyenti kelajakdagi EPS o'sishining har bir birligini baholash imkonini beradi, bunda birdan past bo'lgan PEG koeffitsiyenti aktivning kengayishiga nisbatan qadrsizlanganligini anglatadi, bu esa investorlarga qadrsizlangan o'sish yetakchilarini aniqlashga yordam beradi.
NeoGenomics, Inc. raqobatchilari
LIN (Linde PLC) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Air Products & Chemicals - Narx-foyda va o‘sish multiplikatori|DuPont Corp (DD) - O‘sish sur’atiga tuzatilgan narx-foyda|IP - Narxning foydaga va o‘sish sur’atiga nisbati|PPG (PPG Industries, Inc.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|DOW: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda LyondellBasell Industries N.V. (LYB)|Narxning foydaga va o‘sish sur’atiga nisbati International Flavors & Fragrances Inc|O‘sish sur’atiga tuzatilgan narx-foyda RPM Group RPM|PEG multiplikatori ENTG|suzano.com.br (SUZ) - Narxning sof foyda o‘sishiga nisbati|PEG multiplikatori WLK (Westlake)|Albemarle Corp (ALB) - O‘sish sur’atiga tuzatilgan narx-foyda|ICL - Narxning foydaga va o‘sish sur’atiga nisbati|NEU (Ethyl Corporation) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Eastman Chemical (EMN) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda axalta.com (AXTA)|Narxning foydaga va o‘sish sur’atiga nisbati Element Solutions|Narx-foyda va o‘sish multiplikatori SQM S.A. (SQM)|PEG multiplikatori CE|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Sensient Technologies Inc.|PEG multiplikatori CBT (Cabot Corporation)|HWKN - Narx-foyda va o‘sish multiplikatori|AVNT - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati HB Fuller FUL|MEOH (Methanex Corp.) - Narx-foyda va o‘sish multiplikatori|WD-40 Company Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|CC (The Chemours Company) - PEG multiplikatori|quakerhoughton.com (KWR) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati PureCycle Technologies, Inc. (PCT)|Ashland Inc - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori NGVT (Ingevity Corp.)|IOSP - Narx-foyda va o‘sish multiplikatori|MTX: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati dqsolar.com DQ|Sylvamo (SLVM) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti HUN|AIN (Albany International Inc.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Calumet Corp CLMT|Narxning foydaga va o‘sish sur’atiga nisbati Rogers Corporation (ROG)|SCL - O‘sish sur’atiga tuzatilgan narx-foyda|PEG multiplikatori ECVT (Ecovyst)|REX - Narx-foyda va o‘sish multiplikatori|ASP Isotopes Corp - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti TROX (Tronox Corp)|GSM: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda wlkpartners.com (WLKP)|Narxning foydaga va o‘sish sur’atiga nisbati Compass Minerals International|Narx-foyda va o‘sish multiplikatori Kronos Worldwide Inc (KRO)|PEG multiplikatori MATV|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati LSB Chemical|Narxning foydaga va o‘sish sur’atiga nisbati Braskem S.A. BAK|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati koppers.com (KOP)|ASIX: Narx-foyda va o‘sish multiplikatori|Orion Engineered Carbons - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|rayonieram.com (RYAM) - Narxning foydaga va o‘sish sur’atiga nisbati|Aduro Clean Technologies Corp - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori MAGN|O‘sish sur’atiga tuzatilgan narx-foyda clearwaterpaper.com CLW|Narxning foydaga va o‘sish sur’atiga nisbati Tredegar Corporation (TG)|Core Molding Technologies Inc. - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori FF (FutureFuel Corporation)|Flexible Solutions International Inc. (FSI) - O‘sish sur’atiga tuzatilgan narx-foyda|ALTO - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda 5E Advanced Materials|TSE: PEG multiplikatori|Narxning sof foyda o‘sishiga nisbati Origin Materials ORGN|NTIC (Northern Technologies International Corp.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda LanzaTech Corp LNZA|Narxning foydaga va o‘sish sur’atiga nisbati J-Star Holding Co Ltd (YMAT)|newerahelium.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Bolt Projects BSLK|BioNexus Gene Lab Corp (BGLC) - O‘sish sur’atiga tuzatilgan narx-foyda|GURE - Narxning foydaga va o‘sish sur’atiga nisbati|CN Energy Group. Inc. (CNEY) - Narx-foyda va o‘sish multiplikatori|ALTM: PEG multiplikatori|DNMR - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|GLT (Glatfelter Corp) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Graphex (GRFX)|Narxning foydaga va o‘sish sur’atiga nisbati U.S. Silica Holdings Inc. (SLCA)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Invizyne Corp
